Self-sampling Blood Collection and Storage Devices Market to Reach US$ 423.5 Mn by 2035, Fueled by Decentralized Diagnostics and Technological Innovations

The global healthcare industry is witnessing a significant transformation as decentralized diagnostics and patient-centric healthcare gain momentum. Self-sampling blood collection and storage devices have emerged as a practical solution for remote diagnostics, clinical research, and chronic disease monitoring. These devices enable individuals to collect blood samples safely outside traditional healthcare settings, reducing the need for hospital visits while improving accessibility to diagnostic testing.

According to recent market analysis, the global self-sampling blood collection and storage devices market was valued at US$ 192.4 Mn in 2024 and is projected to reach US$ 423.5 Mn by 2035, expanding at a CAGR of 7.5% during the forecast period from 2025 to 2035.

Preview crucial insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77529

Market Overview: Growing demand for rapid infectious disease screening, increasing adoption of telehealth services, and advancements in microsampling technologies are reshaping the global market landscape. Healthcare providers and pharmaceutical companies are increasingly adopting self-sampling devices to support decentralized clinical trials, improve patient participation, and streamline laboratory workflows.

Innovations such as volumetric microsampling, passive plasma separation, and enhanced dried blood spot (DBS) technologies are significantly improving sample quality and analytical accuracy. These advancements reduce pre-analytical variability while enabling reliable transportation and storage of blood specimens.

North America remained the leading regional market in 2024, accounting for 38.7% of the global revenue, supported by advanced healthcare infrastructure, widespread digital health adoption, and strong clinical research activity.

Key Drivers of Market Growth

Technological innovation continues to be the primary growth catalyst for the self-sampling blood collection and storage devices industry. Improvements in volumetric blood collection technologies and stabilization methods have enhanced compatibility between capillary blood samples and laboratory testing procedures.

Modern collection devices provide accurate sample volumes while minimizing contamination and hematocrit-related variations, increasing confidence among laboratories and healthcare providers.

Strategic collaborations between device manufacturers, diagnostic laboratories, and healthcare organizations are further accelerating commercialization. Partnerships enable seamless integration of remote sample collection with laboratory analysis, simplifying logistics and supporting wider adoption across clinical research and routine diagnostics.

The rising preference for patient-centered healthcare, coupled with the expansion of virtual clinical trials, is also creating sustained demand for reliable self-sampling technologies.

Key Players and Industry Leaders

The competitive landscape features several established medical technology companies investing heavily in research, product innovation, and strategic collaborations.

Leading companies operating in the global self-sampling blood collection and storage devices market include:

• Neoteryx, LLC.
• DBS System SA
• PanoHealth
• Tasso, Inc.
• Seventh Sense Biosystems
• LAMEDITECH
• Capitainer
• Spot On Sciences
• Trajan Scientific and Medical
• Drawbridge Health
• Weavr Health
• Microdrop
• Hemex Health
• Eastern Business Forms, Inc.
• YourBio Health

These companies continue expanding their product portfolios through innovations in microfluidics, dried blood spot technologies, laboratory integration solutions, and home-based blood collection platforms.

Access our report for a comprehensive look at key insights - https://www.transparencymarketresearch.com/selfsampling-blood-collection-and-storage-device-market.html

Key Trends for the Future

One of the most significant trends shaping the industry is the transition from conventional blood collection toward decentralized healthcare ecosystems.

Collection devices represented the largest product segment, accounting for 60.5% of the market in 2024. Their dominance is attributed to improvements in user experience, sample integrity, and compatibility with laboratory workflows.

Healthcare organizations are increasingly adopting quantitative dried blood spot technologies and volumetric microsampling systems to improve diagnostic consistency while reducing patient discomfort.

Another major trend is the integration of self-sampling devices with digital health platforms and laboratory information systems, allowing real-time monitoring, remote diagnostics, and improved patient engagement.

Regulatory support for microsampling technologies is also expected to strengthen commercialization opportunities globally.

New Opportunities and Challenges

The increasing adoption of decentralized clinical trials presents significant growth opportunities for manufacturers. Pharmaceutical companies require reliable remote blood collection methods to recruit diverse patient populations while reducing operational costs.

Expanding healthcare access in underserved regions and increasing demand for home-based chronic disease monitoring are expected to generate additional market opportunities.

However, the industry also faces several challenges.

Manufacturers must ensure consistent analytical accuracy across multiple laboratory settings while complying with evolving regulatory standards. Standardization of sample handling, transportation, and laboratory validation remains essential for broader clinical acceptance.

Furthermore, educating healthcare professionals and patients regarding proper device usage will play a critical role in maximizing adoption rates.

Future Outlook

The long-term outlook for the self-sampling blood collection and storage devices market remains highly positive.

Continuous innovation in microsampling technologies, stronger collaborations between laboratories and manufacturers, and growing acceptance of remote diagnostics are expected to drive sustained market expansion through 2035.

Recent industry developments further highlight this momentum. In September 2025, Trajan Scientific and Medical received Australian regulatory approval for its hemaPEN device, enabling accurate remote collection of dried blood spot samples. In February 2025, IHI launched Project-COMFORT with approximately 51 organizations to standardize microsampling in healthcare and clinical research. Earlier, in March 2024, the U.S. FDA granted 510(k) clearance to RedDrop Dx's RedDrop One blood collection device, marking another important milestone in home-based blood collection technologies.

As healthcare systems increasingly prioritize convenience, accessibility, and digital integration, self-sampling blood collection solutions are expected to become an integral component of future diagnostic workflows worldwide.

Buy this Premium Research Report to access comprehensive analysis - https://www.transparencymarketresearch.com/checkout.php?rep_id=77529<ype=S

Market Segmentation

By Type

• Collection Devices, Storage Devices

By Application

• Disease Management, Health & Wellness, Drug Discovery & Development, Epidemiological Population Health Studies, Others

By End-user

• Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical Industries, Home Care Settings, Others

By Region

• North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Important FAQs with Answers

Q1. How large was the global self-sampling blood collection and storage devices market in 2024?

The market was valued at US$ 192.4 million in 2024.

Q2. What is the projected market value by 2035?

The market is expected to reach US$ 423.5 million by 2035.

Q3. What is the expected CAGR during the forecast period?

The market is projected to grow at a CAGR of 7.5% between 2025 and 2035.

Q4. What are the major growth drivers?

Key drivers include technological innovations in volumetric microsampling and stabilization methods, increasing demand for decentralized diagnostics, and strategic partnerships between device manufacturers and diagnostic laboratories.

Q5. Which region leads the global market?

North America held the largest market share in 2024, accounting for 38.7% of global revenue.

Q6. Which product segment dominated the market?

Collection devices led the market with a 60.5% revenue share in 2024 due to their critical role in ensuring sample quality and laboratory compatibility.

More Related Reports –

Wearable Healthcare Devices Market: https://www.transparencymarketresearch.com/wearable-healthcare-devices-market.html

Aseptic Transfer System Market: https://www.transparencymarketresearch.com/aseptic-transfer-system-market.html

RFID Blood Monitoring Systems Market: https://www.transparencymarketresearch.com/blood-monitoring-systems.html

Transfection Reagents and Equipment Market: https://www.transparencymarketresearch.com/transfection-reagents-equipment-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com